“The idea that Aquablation [treats] any size and any shape of prostate really does seem to hold true for these cohorts of patients,” says Dean Elterman, MD, MSc, FRCSC.
In this video, Dean Elterman, MD, MSc, FRCSC, discusses how Aquablation has revolutionized the ways in which urologists perform procedures and how those procedures result in improved urinary function and quality of life for their patients. Elterman is an associate professor of urology at University of Toronto and an attending urologist at the University Health Network, Toronto, Canada.
Lenvatinib plus pembrolizumab delays all organ tumor progression in advanced RCC
June 7th 2024“Overall, our results continue to support the use of lenvatinib and pembrolizumab as a current standard treatment option in the first-line treatment of [patients with] kidney cancer," says Viktor Grünwald, MD, PhD.